Showing results (121-130 of 589) with videos related to

Sort By:
Pageof 59
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 24, 2021
Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of ComorbiditiesDongyu Zhang, Tina D Tailor, Chul Kim, et al.
The Oncologist|October 26, 2020
Emerging Immunotherapies in the Treatment of Brain MetastasesEdwin Nieblas-Bedolla, Naema Nayyar, Mohini Singh, et al.
The American Journal of the Medical Sciences|November 22, 2007
Multicentric Castleman's disease masquerading as HIV-related lymphomaFarshid Dayyani, Liron Pantanowitz, Tom G Sandridge, et al.
Canadian Respiratory Journal|August 22, 2008
Residual hemothorax after chest tube placement correlates with increased risk of empyema following traumatic injuryRiyad Karmy-Jones, Michele Holevar, Ryan J Sullivan, et al.
JCO Oncology Practice|December 1, 2023
Systemic Therapy for Melanoma: ASCO Guideline Update Q and AVernon K Sondak, Michael B Atkins, Hans Messersmith, et al.
Journal of Medical Economics|October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysisVictor Barzey, Michael B Atkins, Louis P Garrison, et al.
Clinical Genitourinary Cancer|February 14, 2009
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinomaKathryn A Bylow, Michael B Atkins, Edwin M Posadas, et al.
Seminars in Oncology|December 8, 2009
Clinical trial experience with temsirolimus in patients with advanced renal cell carcinomaGary R Hudes, Anna Berkenblit, Jay Feingold, et al.
The American Journal of Dermatopathology|August 20, 2016
Discordance Between Cobas BRAF V600 Testing and VE1 Immunohistochemistry in a Melanoma Patient With Bone Marrow MetastasesSuthee Rapisuwon, Klaus J Busam, Kellie Parks, et al.
Pageof 59